Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
---|
05/12/2010 | CN101057854B Application of cycloartane type triterpenoids compound of cimicifuga rhizome for anti-osteoporosis and menopausal syndrome |
05/12/2010 | CN101032545B Novel purpose of Chinese traditional medicine homonoia riparia |
05/12/2010 | CN101015650B Zhuifengtouguhuoluo pills (capsule) and its preparation process |
05/12/2010 | CN101002864B Decoction for treating old lumbar soft tissue injury, and its preparing method |
05/12/2010 | CN100998827B Decoction for treating waist sprain and its preparation method |
05/12/2010 | CN100998826B Decoction medicine for treating omitis and its preparation method |
05/11/2010 | US7714120 Humanized anti-IL-1 beta antibodies |
05/11/2010 | US7714026 Pharmaceutical composition containing bakuchiol for treating woman osteoporosis |
05/11/2010 | US7713987 N2-Chlorocarbonyl-N4-(2,2-dimethyl-3-oxo-4H-5-pyrido[1,4]oxazin-6-yl)-5-fluoro-N2-(3,4,5-trimethoxyphenyl)-2,4-pyrimidinediamine; kinase inhibitors; breast cancer; inhibiting signal transduction cascades in which Syk plays a role |
05/11/2010 | US7713973 Kinase inhibitors |
05/11/2010 | US7713963 Acylated indanyl amines and their use as pharmaceuticals |
05/11/2010 | US7713940 Water-soluble isoflavone composition, process for producing the same, and use thereof |
05/11/2010 | US7713543 Elastin stabilization of connective tissue |
05/11/2010 | US7713529 Methods for treating and preventing infectious disease |
05/11/2010 | CA2434670C Dihydro-triterpenes in the treatment of viral infections, cardiovascular disease, inflammation, hypersensitivity or pain |
05/11/2010 | CA2422299C Triazole compounds useful as protein kinase inhibitors |
05/11/2010 | CA2412968C Substituted pyridines as selective cyclooxygenase-2 inhibitors |
05/11/2010 | CA2410177C Thrombin receptor antagonists |
05/11/2010 | CA2392570C 4-pyrimidinyl-n-acyl-l-phenylalanines |
05/06/2010 | WO2010050783A2 Novel compound with spiro chiral carbon backbone, preparation method thereof, and pharmaceutical composition containing the same |
05/06/2010 | WO2010050513A1 Polypeptide having function to increase calcium concentration in osteoblast |
05/06/2010 | WO2010050461A1 Novel amide derivative and use thereof as medicine |
05/06/2010 | WO2010049898A1 Injectable polydeoxyribonucleotide composition for the treatment of osteoarticular diseases |
05/06/2010 | WO2010049635A1 Tropane urea derivatives, preparation thereof and therapeutic application thereof as modulators of the activity of 11betahsd1 |
05/06/2010 | WO2010049525A1 Choline and tromethamine salt of licofelone |
05/06/2010 | WO2010048955A1 Composition comprising a glycoside of a mono- or diacyiglycerol compound and an oil rich in n-3 polyunsaturated fatty acids, a method of producing the composition and use of the composition |
05/06/2010 | WO2010012964A3 Thiophene-2-carboxamide derivatives, preparation thereof and therapeutic use thereof |
05/06/2010 | WO2010009129A3 Methods of treating autoimmune diseases using cd4 antibodies |
05/06/2010 | WO2009106749A3 Derivatives of n-heterocyclic-imidazo[1,2-a]pyridine-2-carboxamides, preparation thereof and therapeutic application thereof |
05/06/2010 | US20100113820 asthma, allergic conditions such as rhinitis, inflammatory bowel disease such as ulcerative colitis and Crohn's disease, rheumatoid arthritis, atopic dermatitis, multiple sclerosis; condensing N-(2,6-Difluorobenzoyl)-4-(2,6-dimethoxy-4-formal methylphenyl)-L-phenylalanine ethyl ester with ethanol |
05/06/2010 | US20100113796 Indole derivatives as s1p1 receptor |
05/06/2010 | US20100113742 Modified polypeptides stabilized in a desired conformation and methods for producing same |
05/06/2010 | US20100113611 Novel use of hydroxytyrosol |
05/06/2010 | US20100113549 Pyrrolidine compounds |
05/06/2010 | US20100113547 Novel imidazolidine compounds as androgen receptor modulators |
05/06/2010 | US20100113541 Crystal forms of 2-(3-fluoro-4-hydroxyphenyl)-7-vinyl-1,3-benzoxazol-5-ol |
05/06/2010 | US20100113538 N-hydroxy-4- benzamidine 2 ethansulfonic acid salt, process for the preparation thereof and pharmaceutical composition comprising the same |
05/06/2010 | US20100113532 MODULATORS OF THE GLUCOCORTICOID RECEPTOR, AP-1, AND/OR NF-kB ACTIVITY AND USE THEREOF |
05/06/2010 | US20100113531 Thiazolidine derivatives as orexin receptor antagonists |
05/06/2010 | US20100113519 1,5-Dideoxy-1,5-imino-D-glucitol Compounds |
05/06/2010 | US20100113485 Piperidinylamino-thieno[2,3-D] Pyrimidine Compounds |
05/06/2010 | US20100113472 Compounds for the treatment of osteoporosis and cancers |
05/06/2010 | US20100113462 Substituted benzoylamino-indan-2-carboxylic acids and related compounds |
05/06/2010 | US20100113455 Method of reducing intraosseous hypertension |
05/06/2010 | US20100113435 Inhibitors of 11-beta-hydroxy steriod dehydrogenase type 1 |
05/06/2010 | US20100113395 Low dosage forms of risedronate or its salts |
05/06/2010 | US20100113388 8-azaprostaglandin derivative compound and agent comprising the compound as active ingredient |
05/06/2010 | US20100113327 Methods for controlling mineralization of extracellular matrix, therapeutic methods based thereon and medicaments for use therein |
05/06/2010 | US20100112101 Bio-availability/bio-efficacy enhancing activity of stevia rebaudiana and extracts and fractions and compounds thereof |
05/06/2010 | US20100112083 Pharmaceutical product for modulating bone formation, process for modulating bone formation |
05/06/2010 | US20100112028 Composite material for use as protein carrier |
05/06/2010 | US20100112003 Bifidobacterium in the treatment of inflammatory disease |
05/06/2010 | US20100111995 Antigen conjugates and uses thereof |
05/06/2010 | US20100111970 Anti-NGF Antibodies and Methods Using Same |
05/06/2010 | US20100111946 Inhibiting activation with human anti-factor c3 antibodies and use thereof |
05/06/2010 | US20100111910 Treatment of excessive neovascularization |
05/06/2010 | US20100111906 Volume maintaining osteoinductive/osteoconductive compositions |
05/06/2010 | US20100111905 Methods for improved engraftment following stem cell transplantation |
05/06/2010 | US20100111853 Antibodies that bind to il-12 and methods of purifying the same |
05/06/2010 | US20100111840 Stabilized therapeutic and imaging agents |
05/06/2010 | CA2742364A1 Novel compound with spiro chiral carbon backbone, preparation method thereof, and pharmaceutical composition containing the same |
05/06/2010 | CA2741941A1 Choline and tromethamine salt of licofelone |
05/06/2010 | CA2741661A1 Novel amide derivative and use thereof as medicine |
05/05/2010 | EP2182003A1 Peptide capable of binding to immunoglobulin |
05/05/2010 | EP1957452B1 Novel forms of [r-(r*,r*)]-2-(4-fluorophenyl)-b,b-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1h-pyrrole-1-hept anoic acid magnesium |
05/05/2010 | EP1485100B1 Azinylaminoazoles as inhibitors of protein kinases |
05/05/2010 | EP1414486B1 Use of glp-2 in combination with another therapeutic agent in bone-related disorders |
05/05/2010 | EP1326847B1 (2s)-2-(adamantan-1-ylmethoxycarbonylamino)-3-(4-(2-(1,4,5,6-tetrahydropyrimidin-2-ylcarbamoyl)ethyl)benzoylamino)propionic acid isopropyl ester, its preparation and its use |
05/05/2010 | EP1167366B1 Amine derivatives |
05/05/2010 | EP1166788B1 Remedies for joint diseases |
05/05/2010 | EP1115398B1 Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof |
05/05/2010 | CN1985906B Specific medicine for treating rheumatism and bone spur |
05/05/2010 | CN1964730B Herbal compositions for prevention and treatment rheumatic and inflammatory diseases and method of preparing the same |
05/05/2010 | CN1816353B Medicinal composition for preventing or treating Th1 type immunological disease |
05/05/2010 | CN1649569B Controlled release dosage forms |
05/05/2010 | CN1630526B Systems and methods for treating patients with processed lipoaspirate cells |
05/05/2010 | CN1420924B Recombinant human alpha-L-iduronidase, method for producing and purifying same and method for treating disorders including deficiency thereof |
05/05/2010 | CN101700395A Ointment for curing hyperosteogeny |
05/05/2010 | CN101700389A Traditional Chinese medicine composite for curing rheumatism and rheumatoid diseases |
05/05/2010 | CN101700388A Traditional Chinese medicine for treating trauma type cervical spondylosis |
05/05/2010 | CN101700380A Traditional Chinese medicine for curing rheumatoid arthritis |
05/05/2010 | CN101700360A Chinese medicine prescription for curing bi syndrome |
05/05/2010 | CN101700353A Drug for curing and preventing cervical vertebra diseases, preparation method and application method thereof |
05/05/2010 | CN101700331A Bone joiner spray |
05/05/2010 | CN101700325A Medicine for treating sciatica caused by protrusion of lubar intervertebral disc |
05/05/2010 | CN101700314A Traditional Chinese medicine extract drying method for preparing drug for curing osteoporosis |
05/05/2010 | CN101700308A Paste for treating hyperosteogeny |
05/05/2010 | CN101700303A Traditional Chinese medicine composite used for treating cervical spondylosis |
05/05/2010 | CN101700302A Oral traditional Chinese medicine composition for treating osteoporosis |
05/05/2010 | CN101700277A Sustained-release pill of total alkaloids from strychnos and method for preparing same |
05/05/2010 | CN101700274A Compound capable of enhancing bone density |
05/05/2010 | CN101700272A Traditional Chinese medicine for curing cervical spondylosis |
05/05/2010 | CN101700249A Pharmaceutical composition for preventing and treating rheumatoid arthritis |
05/05/2010 | CN101700241A Raloxifene emplastrum preparation and preparation method thereof |
05/05/2010 | CN101700224A Method for preparing oral chondroitin sulfate nanoemulsion |
05/05/2010 | CN101700218A Skin whitening, moisturizing and nourishing gel and method for preparing same |
05/05/2010 | CN101700162A Nano-silver anti-bacterial anion far infrared multifunctional mattress (batts) |
05/05/2010 | CN101022800B Pharmaceutical composition for the treatment of bone fracture |
05/04/2010 | US7709669 Aspirin-triggered lipid mediators |
05/04/2010 | US7709664 E.g., 3-arylmethyl-7-hydroxy-coumarins as intermediates; affects both the Tumor Necrosis Factor alpha level and transcription activity of NuclearFactor kappa Beta; antiimmunoinflammatory agents and autoimmune properties; antiarthritis agents; rheummatic diseases; osteoporosis; leukemia |